Financial results - PHARMACORP INNOVATION SRL

Financial Summary - Pharmacorp Innovation Srl
Unique identification code: 28750223
Registration number: J2011008044408
Nace: 7210
Sales - Ron
-
Net Profit - Ron
-4.714
Employees
1
Open Account
Company Pharmacorp Innovation Srl with Fiscal Code 28750223 recorded a turnover of 2024 of - , with a net profit of -4.714 and having an average number of employees of 1. The company operates in the field of Cercetare-dezvoltare în ştiinţe naturale şi inginerie having the NACE code 7210.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharmacorp Innovation Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 0 1.670 6.582 3.726 7.334 5.092 708 2.028 142 0
Total Income - EUR 102.375 94.230 38.756 45.509 50.828 33.346 26.993 35.871 28.465 11.660
Total Expenses - EUR 101.946 93.885 35.862 44.286 48.243 33.182 30.628 35.694 30.955 16.374
Gross Profit/Loss - EUR 430 344 2.894 1.224 2.585 164 -3.635 177 -2.491 -4.714
Net Profit/Loss - EUR 430 328 2.801 1.224 2.513 113 -3.643 157 -2.492 -4.714
Employees 4 3 2 2 2 2 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharmacorp Innovation Srl

Rating financiar

Financial Rating -
PHARMACORP INNOVATION SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharmacorp Innovation Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmacorp Innovation Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmacorp Innovation Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmacorp Innovation Srl - CUI 28750223

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 7.207 7.176 6.892 11.595 12.389 10.777 10.249 9.722 10.550 10.129
Current Assets 22.059 19.130 18.590 11.243 4.944 8.301 6.181 8.111 7.437 7.236
Inventories 17.604 11.279 11.089 8.876 4.710 6.069 5.935 5.953 6.198 6.163
Receivables 0 1.670 0 519 0 2.007 0 2.028 1.011 1.005
Cash 4.455 6.181 7.502 1.848 235 225 246 131 228 67
Shareholders Funds 4.256 4.621 7.344 8.433 10.783 10.692 6.813 6.991 4.477 -262
Social Capital 225 303 298 292 287 281 275 276 275 273
Debts 15.948 21.685 18.138 14.405 6.550 8.386 9.617 10.842 13.510 17.627
Income in Advance 9.061 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7210 - 7210"
CAEN Financial Year 7211
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 7.236 euro in 2024 which includes Inventories of 6.163 euro, Receivables of 1.005 euro and cash availability of 67 euro.
The company's Equity was valued at -262 euro, while total Liabilities amounted to 17.627 euro. Equity decreased by -4.714 euro, from 4.477 euro in 2023, to -262 in 2024.

Risk Reports Prices

Reviews - Pharmacorp Innovation Srl

Comments - Pharmacorp Innovation Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.